Approval · Notice of Compliance 2798 · 1998
BAYCOL: Notice of Compliance 2798
Issued February 18, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2798
- Date
- February 18, 1998
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
Medicinal ingredients
- CERIVASTATIN 0.2 MG per TAB
- CERIVASTATIN 0.3 MG per TAB